Evidence map›Paper›PMID 21460065›Full record

ArticleCardiovascular research2011

Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.

Yoshinori Nishijima, Arun Sridhar, Ingrid Bonilla, Murugesan Velayutham, Mahmood Khan, Radmila Terentyeva, Chun Li, Periannan Kuppusamy, Terry S Elton, Dmitry Terentyev and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 86 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2020
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Yoshinori NishijimaCollege of Pharmacy, The Ohio State University, 500 W. 12th Avenue, Columbus, OH 43210, USA.
Arun Sridhar
Ingrid Bonilla
Murugesan Velayutham
Mahmood Khan
Radmila Terentyeva
Chun Li
Periannan Kuppusamy
Terry S Elton
Dmitry Terentyev
Sandor Györke
Jay L Zweier
Arturo J Cardounel
Cynthia A Carnes
The Ohio State University · USLung Institute · USGlaxoSmithKline (United Kingdom) · GB

Funding

Ryanodine Receptor Channels in Heart FailureR01HL074045 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GYORKE, SANDOR · 2003 to 2024
$8.2M
OXYGEN RADICALS AND NITRIC OXIDE IN POSTISCHEMIC INJURYR01HL063744 · NHLBI · OHIO STATE UNIVERSITY · PI ZWEIER, JAY LOUIS · 2000 to 2009
$5.2M
MEASURE OF FREE RADICAL GENERATION IN HEARTR01HL038324 · NHLBI · OHIO STATE UNIVERSITY · PI ZWEIER, JAY LOUIS · 1992 to 2010
$3.5M
HUMAN ANGIOTENSIN II RECEPTOR GENE REGULATIONR01HL048848 · NHLBI · OHIO STATE UNIVERSITY · PI ELTON, TERRY S · 1997 to 2009
$2.1M
Heart Failure and Atrial FibrillationR01HL089836 · NHLBI · OHIO STATE UNIVERSITY · PI CARNES, CYNTHIA A · 2008 to 2012
$2.1M
MEASUREMENT OF FREE RADICAL GENERATION IN THE HEARTR29HL038324 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI ZWEIER, JAY LOUIS · 1987 to 1991
–
ANGIOTENSIN II RECEPTOR GENE EXPRESSIONR29HL048848 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ELTON, TERRY S · 1992 to 1996
–
NHLBI NIH HHS HL048848NHLBI NIH HHS HL074045NHLBI NIH HHS HL089836-03NHLBI NIH HHS HL38324NHLBI NIH HHS HL63744NHLBI NIH HHS R01 HL038324NHLBI NIH HHS R01 HL048848NHLBI NIH HHS R01 HL063744NHLBI NIH HHS R01 HL074045NHLBI NIH HHS R01 HL089836NHLBI NIH HHS R29 HL048848
6 · The paper itself

Abstract

aimsHeart failure is a common antecedent to atrial fibrillation; both heart failure and atrial fibrillation are associated with increased myocardial oxidative stress. Chronic canine heart failure reduces atrial action potential duration and atrial refractoriness. We hypothesized that inducible nitric oxide synthase 2 (NOS2) contributes to atrial oxidative stress and electrophysiologic alterations. METHODS AND

resultsA 16-week canine tachypacing model of heart failure was used (n= 21). At 10 weeks, dogs were randomized to either placebo (n = 12) or active treatment (n = 9) with NOS cofactor, tetrahydrobiopterin (BH(4), 50 mg), and NOS substrate (L-arginine, 3 g) twice daily for 6 weeks. A group of matched controls (n = 7) was used for comparison. Heart failure increased atrial NOS2 and reduced atrial BH(4), while L-arginine was unchanged. Treatment reduced inducible atrial fibrillation and normalized the heart failure-induced shortening of the left atrial myocyte action potential duration. Treatment increased atrial [BH(4)] while [L-arginine] was unchanged. Treatment did not improve left ventricular function or dimensions. Heart failure-induced reductions in atrial [BH(4)] resulted in NOS uncoupling, as measured by NO and superoxide anion (O(2)(·-)) production, while BH(4) and L-arginine treatment normalized NO and O(2)(·-). Heart failure resulted in left atrial oxidative stress, which was attenuated by BH(4) and L-arginine treatment.

conclusionChronic non-ischaemic heart failure results in atrial oxidative stress and electrophysiologic abnormalities by depletion of BH(4) and uncoupling of NOS2. Modulation of NOS2 activity by repletion of BH(4) may be a safe and effective approach to reduce the frequency of atrial arrhythmias during heart failure.

Indexed as

Atrial Function, LeftAction PotentialsAnimalsArginineAtrial FibrillationBiopterinsCardiac Pacing, ArtificialDisease Models, AnimalDogsFemaleHeart AtriaHeart FailureKineticsMaleMyocardiumNitric OxideArginineBiopterinsNitric OxideNitric Oxide Synthase Type IIsapropterinSuperoxides

Identifiers

PMID21460065
PMCPMC3112023
OpenAlexW2096011595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.